629 |
Optical Coherence Tomography Guided Distal Left Main Treatment with Bioresorbable Scaffold: Two Years Follow-Up |
Indulis Kumsars |
Dec. 08. 15 |
628 |
[Review in 2015] Physiology |
Jung-Min Ahn |
Dec. 08. 15 |
627 |
[Review in 2015] Imaging |
Soo-Jin Kang |
Dec. 08. 15 |
626 |
Relationship Between FFR and Clinical Outcome: Data from IRIS-FFR Registry |
Seung-Jung Park |
Dec. 08. 15 |
625 |
CONTRAST Study: Diagnostic Performance of Contrast FFR Versus Resting Physiology |
Nils Johnson |
Dec. 08. 15 |
624 |
Update on FAME 3 Trial |
William F. Fearon |
Dec. 08. 15 |
623 |
5-Year F/U of FAME I and Outcomes of 1500 Proximal LADs with Intermediate FFR (0.70-0.85) |
Nico Pijls |
Dec. 08. 15 |
622 |
[Integrated Use of FFR and IVUS: Case Based Learning] Non-Left Main |
Bon-Kwon Koo |
Dec. 08. 15 |
621 |
[Integrated Use of FFR and IVUS: Case Based Learning] Left Main |
Chang-Wook Nam |
Dec. 08. 15 |
620 |
Discordance of FFR and CFR: Understanding, Clinical Relevancy, and DEFINE-FLOW Study |
Nils Johnson |
Dec. 08. 15 |